Literature DB >> 8026985

Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease.

Y Shindo1, S Ohno, T Yamamoto, S Nakamura, H Inoko.   

Abstract

VKH disease is a bilateral panuveitis and has been known to be closely associated with the particular HLA class II antigens HLA-DR4 and -DQ4, defined by serologic typing. In this study, 63 Japanese VKH patients were analyzed for HLA class II alleles at the DNA level using the PCR-RFLP method. The DRB1*04 alleles encoding the serologic specificity DR4 were found in 100% of the VKH patients carrying DRB1*0405 or DRB1*0410. By statistical analysis, only DRB1*0405 was found to be significantly increased as compared to the healthy controls (RR = 46.7 and pc < 1 x 10(-5)). As to the DQB1 locus, all the patients carried DQB1*0401 or DQB1*0402 expressing the serologic DQ4 specificity, which is in a strong linkage disequilibrium with DRB1*0405 or DRB1*0410 in a Japanese population, respectively. Only DQB1*0401 showed a statistically significant increase as compared to the healthy controls (RR = 41.3 and pc < 1 x 10(-5)). Comparison of the amino acid sequences of these DRB1 and DQB1 alleles indicates that Ser at position 57 of DRB1 and/or Glu at position 70 and Asp at position 71 of DQB1 plays a crucial role in determining the susceptibility to VKH disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026985     DOI: 10.1016/0198-8859(94)90257-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  22 in total

Review 1.  Polymerase chain reaction in the diagnosis of uveitis.

Authors:  Chi-Chao Chan; DeFen Shen; Jingsheng Tuo
Journal:  Int Ophthalmol Clin       Date:  2005

Review 2.  Current approach in the diagnosis and management of panuveitis.

Authors:  Reema Bansal; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

Review 3.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

4.  High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease.

Authors:  N Yawata; S Nakamura; M Kijima; N Ikai; M Kanai; M Sugita; S Ohno
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

Review 5.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

6.  Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease.

Authors:  M Kitamura; N Kitaichi; M Takeuchi; H Kitamei; K Namba; S-I Yamagishi; K Iwabuchi; K Onoé; S Ohno
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

7.  HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.

Authors:  Alia Iqniebi; Ameera Gaafar; Atia Sheereen; Abdullah Al-Suliman; Gamal Mohamed; Khaled Al-Hussein; Khalid F Tabbara
Journal:  Mol Vis       Date:  2009-09-12       Impact factor: 2.367

8.  A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.

Authors:  Jean-Marie Tiercy; Sivakumar R Rathinam; Marianne Gex-Fabry; Edoardo Baglivo
Journal:  Mol Vis       Date:  2010-03-05       Impact factor: 2.367

9.  Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.

Authors:  S Otani; T Sakurai; K Yamamoto; T Fujita; Y Matsuzaki; Y Goto; Y Ando; S Suzuki; M Usui; M Takeuchi; Y Kawakami
Journal:  Br J Ophthalmol       Date:  2006-02-15       Impact factor: 4.638

10.  Polymerase chain reaction in intraocular inflammation.

Authors:  Krishnendu Nandi; Prabhat Ranjan; Lily Therese; Jyotirmay Biswas
Journal:  Open Ophthalmol J       Date:  2008-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.